Fact CheckerSign in

NCT05364593Completed

Evaluation of Point-of-care Ultrasound in Children From 6 Months to 15 Years With Presumptive Tuberculosis

Evaluating Point-of-care Ultrasound to Improve Tuberculosis Diagnosis in Children

Source: ClinicalTrials.gov · Last updated 9 Jan 2024

Brief summary (registry, in English)

Diagnosis of tuberculosis (TB) in children is particularly challenging in low and middle-income countries (LMIC), and a high number of children remain undiagnosed and untreated. A delay in diagnosis can lead to an increase in preventable morbidity and mortality. Point-of-care ultrasound (POCUS) is a bedside, non-invasive, inexpensive imaging tool, and TB-focused POCUS has been used and validated for adults with HIV. This study aims to describe the TB-focused POCUS findings for children with presumptive TB aged between 6 months and 15 years old, and to stratify the results per HIV, nutritional status and age. This is a Médecins Sans Frontières (MSF) multicentric study which takes place in Guinea Bissau and South Sudan.

Status (registry)
Completed
Study type
Observational
Enrollment
576 (actual)
First submitted
26 Apr 2022
Start date
26 Jun 2019
Primary completion date
30 Jun 2023
Lead sponsor
Medecins Sans Frontieres, Spain
Diseases
Tuberculosis
NCT number
NCT05364593

What you commit to

  • Study type: Observational
  • Participants enrolled: 576
  • From 26 Jun 2019 to the primary completion date, 30 Jun 2023
  • 2 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have received TB treatment for \> 1 day in the last 3 months

Other

  • Informed consent not provided by legal responsible or companion

Who the study is looking for

  • Any child from 6 months of life to 15 years old
  • Presumptive TB according to diagnostic criteria
  • Informed consent provided by legal responsible or companion

Age in the registry: 6 months to 15 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Simao Mendes hospital
Coordinator of this site? Confirm its status
BissauGuinea-BissauUnknown status
Malakal hospital
Coordinator of this site? Confirm its status
MalakalSouth SudanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.